RACHEAL POSEY: Open Payments
NPI 1891422275 · SUMTER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 40 payments from 17 companies in 2025. Trend: 2023 $87 · 2024 $509 · 2025 $786
Food & beverage: $786
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $203 |
| AstraZeneca Pharmaceuticals LP | 6 | $181 |
| Amgen Inc. | 4 | $62 |
| PFIZER INC. | 3 | $57 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $36 |
| Lilly USA, LLC | 2 | $35 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Corcept Therapeutics | 1 | $19 |
Products named: Ozempic, FARXIGA, OTEZLA, Auvelity, Veozah, MOUNJARO, ELIQUIS, VYNDAQEL.
Industry payments across SC — which companies pay providers there.
